Similar articles

• Autoantibodies related to systemic autoimmune rheumatic diseases in severely ill patients with COVID-19.

  Vlachoyiannopoulos PG, Magira E, Alexopoulos H, Jahaj E, Theophilopoulou K, Kotanidou A, Tzioufas AG. Vlachoyiannopoulos PG, et al. Ann Rheum Dis. 2020 Dec;79(12):1661-1663. doi: 10.1136/annrheumdis-2020-218009. Epub 2020 Jun 24. Ann Rheum Dis. 2020. PMID: 32581086 No abstract available.
• Update on autoantibodies to intracellular antigens in systemic rheumatic diseases.

  Nakamura RM, Tan EM. Nakamura RM, et al. Clin Lab Med. 1992 Mar;12(1):1-23. Clin Lab Med. 1992. PMID: 1563236 Review.
• [Interdisciplinary Forum on Autoimmune Disease Research: guidelines].

  Sinico RA; Forum interdisciplinare per la ricerca sulle malattie autoimmuni (F.I.R.M.A.). Sinico RA, et al. G Ital Nefrol. 2002 Mar-Apr;19(2):212-24. G Ital Nefrol. 2002. PMID: 14518478 Italian. No abstract available.
• Are we at a stage to predict autoimmune rheumatic diseases?

  Bizzaro N, Tozzoli R, Shoenfeld Y. Bizzaro N, et al. Arthritis Rheum. 2007 Jun;56(6):1736-44. doi: 10.1002/art.22708. Arthritis Rheum. 2007. PMID: 17530702 Review. No abstract available.
• Autoantibodies associated with rheumatic diseases.

  Griesmacher A, Peichl P. Griesmacher A, et al. Clin Chem Lab Med. 2001 Mar;39(3):189-208. doi: 10.1515/CCLM.2001.031. Clin Chem Lab Med. 2001. PMID: 11350015 Review.